key: cord-0861399-ycxxpze2 authors: Drak Alsibai, Kinan title: Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: a potential role of cellular FURIN in the pathogenesis of SARS-CoV-2 date: 2020-05-30 journal: Med Hypotheses DOI: 10.1016/j.mehy.2020.109893 sha: 4a54f0a24836e922a6f29943132d8b8041855e94 doc_id: 861399 cord_uid: ycxxpze2 Recently, a mini-review was published in the Medical Hypotheses journal by Usul Afsar entitled 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of Furin and relevance with cancer. Previous studies have pointed out that disruption of the proteolytic cleavage of proteins can promote infectious and non-infectious diseases. The last few weeks have been marked by an important revelation concerning the pathophysiology of SARS-CoV-2. This new coronavirus disease (COVID-19) is a highly contagious and transmissible acute respiratory infectious disorder. SARS-CoV-2 is composed of RNA-dependent RNA polymerase and structural proteins including Spike protein (S protein). Interestingly, the FURIN, one of the proproteins of the convertase family, play a crucial role in the maturation of viral glycoproteins. In addition, many viruses including coronaviruses, exploit FURIN for the activation of their glycoproteins. Recent data indicate that SARS-CoV-2 enters human cells by binding to angiotensin-converting enzyme 2. Subsequently, the S protein is cleaved by receptor transmembrane serine protease 2 with the help of FURIN which facilitates the entry of the virus into the cell after binding. Furthermore, it seems that FURIN is implicated in the pathogenesis of SRS-CoV-2 and potentially in the increased rates of human-to-human transmission. The FURIN, one of the proproteins of the convertase family, play a crucial role in the maturation of viral glycoproteins (1, 2) . Interestingly, many viruses including coronaviruses exploit FURIN for the activation of their glycoproteins (2) . The last few weeks have been marked by an important revelation concerning the pathophysiology of SARS-CoV-2 (Severe Acute Respiratory Syndrome with Coronavirus 2). This new coronavirus disease (COVID-19) is a highly contagious and highly transmitted acute respiratory infectious disorder, which by the end of April 2020 has caused more than 200,000 deaths worldwide (according to World Health Organization data). SARS-CoV-2 is composed of RNA-dependent RNA polymerase (RdRp), structural proteins including spike protein (S protein), envelope and membrane proteins and nucleocapsid phosphoprotein, and a set of non-structural proteins (ORFs) (3). Previous studies have shown that coronaviruses use different mechanisms of cell entry in terms of membrane fusion activities (4), by binding to the angiotensin-converting enzyme 2 (ACE2), via viral glycoprotein (S protein) (5, 6) . Thus, ACE2 can be considered as a functional receptor for coronavirus to enter host cells (7) . ACE2 is a chimeric monocarboxypeptidase protein; homologous to ACE that converts angiotensin II (Ang II) into angiotensin 1-7 (8, 9) . ACE2 plays a key role in the regulation of the renin-angiotensin system (RAS), which is implicated in coronavirus-induced lung injury (10) . Recently, SARS-CoV-2 has been shown to enter human cells by binding to ACE2. Subsequently, the S protein is cleaved by receptor transmembrane serine protease 2 (TMPRSS2) (11) , with the help of FURIN which facilitates the entry of the virus into the cell after binding (12, 13) . Theoretically, other human's proteases (cathepsin L and B, elastase, trypsin and factor X) may be involved in this process (14) . The protein cleavage between the S1 and S2 units is the most important step for virus entry into host cells, which is performed by the protease TMPRSS2. This cleavage is a crucial step because after S1 detachment, the remaining viral S2 unit undergoes a conformational reconfiguration that completes fusion between the viral and cell membrane, with subsequent entry of the virus into the cell, release of its contents, replication and infection of other cells (15) . This role is confirmed by the fact that the use of camostat mesylate, a TMPSRR2 inhibitor, partially blocks the entry of SARS-CoV-2 into host cells (11) . Interestingly, Lukassen S and colleagues have shown that TMPRSS2 is highly expressed in lung tissue and sub-segmental bronchial branches (12) . In addition, their study revealed that ACE2 is mainly expressed in transient secretory cells. These cells show enrichment of pathways related to RHO GTPase function and viral processes, suggesting an increased susceptibility to SARS-CoV-2 infection (12) . The RHO GTPase family regulates many aspects of intracellular dynamics and activates viral processes regulating pathways. These processes are related to membrane remodelling and the immune system (16). It is interesting to note that protease-dependent non-endosomal replication of the SARS coronavirus is much more frequent (up to 1000 times) than endosomal replication (17). Therefore, according to the experimental results previously reported (12, 16) , SARS-CoV-2 can also enter the cell by the non-endosomal route, either through the involvement of proteases including FURIN, or through the membrane remodelling way in the transient secretory cells, which include RHO GTPases. human-to-human transmission. The SARS-CoV-2 S protein contains four redundant FURIN cleavage sites (PRRA motif) (12) . Involvement of this protease during S protein priming could increase the entry of CoV-2-SARS into cells. FURIN can be secreted as an active isoform (18) , and therefore can act in neighbouring cells that do not express it. These arguments supported the hypothesis of a role for FURIN in increasing human-to-human transmission rates of CoV-2-SARS. FURIN may also play a role in the higher pathogenicity of CoV2-SARS due to increased affinity for the ACE2 receptor (12, (19) (20) (21) . These experimental studies were supported a few days ago by important data from single-cell RNA sequencing (scRNA-seq), revealing that the cells that co-express ACE2 and TMPRSS2 are type II pneumocytes (lungs), absorbent ileal enterocytes (small intestine) and nasal secretory cells (nasal cavity) (22) . Moreover, ACE2 is expressed in the heart, vessels, kidney, testis and brain. The scRNA-seq showed that les interferons (IFNs) regulate ACE2 and promote the ability of SARS-CoV-2 to maintain cellular targets in neighbouring human upper airway epithelial cells. Even more striking, the authors found that the ACE2 gene is stimulated by human INF in vitro, and they were able to extend their discovery to viral infections in vivo (22) . These data suggest that SARS-CoV-2 may exploit the positive regulation of ACE2, to enhance infection. In addition, this broad expression of ACE2 associated with TMPRSS2 and FURIN may explain the high pathogenic potential of SARS-CoV-2 described in some COVID-19 patients with severe multi-organ dysfunction. Obviously, the confirmation of such a hypothesis requires analyses of the level of FURIN expression in different tissues, especially those with high levels of ACE2 expression. By consulting the human protein atlas site Interestingly, the FURIN is a direct target of the Interleukin/STAT pathway, and upregulated in T helper 1 (Th1) cells. FURIN expressed by T lymphocytes is essential for host resistance against certain pathogen, and for the generation of pathogen-specific lymphocytes, including Th1 cells. Thus, FURIN is also considered to be a central regulator of cell-mediated immunity (26) . Accordingly, the GSEA analysis of SARS-CoV specimens revealed that T-cell cytokine secretion was increased and T-cell activation was stimulated (22) . Moreover, the level of ACE2 in SARS-CoV infected epithelial cells was significantly correlated with TNFα and Th1, Th2 and Th17 cells (22) . II has been shown to cleave membrane-anchored ACE2, releasing an active form of circulating ACE2 with loss of catalytic activity of the remaining part of the membraneanchored enzyme (28) . A high level of circulating ACE2 is a marker of a disease state indicating increased RAS activity and associated with a poorer prognosis (29) . Finally, there is considerable evidence that the expression or aberrant activity of FURIN can lead to a variety of disorders such as infectious and non-infectious diseases, metabolic disorders and even cancer (2) . In addition, the data cited above have shown evidence of the involvement of FURIN in the cleavage and pathogenicity of SARS-CoV-2. Current therapeutic approaches propose targeting FURIN either at the protein level or by focusing on its RNA (30) . Although FURINE is already considered a potential therapeutic target in infectious diseases, however, the use of host protease inhibitors, particularly those directed against FURINE, as a therapeutic strategy in COVID-19 seems premature and requires further clarification of its role in the cleavage and pathogenesis of SARS-CoV-2. Sincerely yours. No funding to declare. The author declare that he has no competing interests. COVID-19) infection: Crucıalıty of Furın and relevance wıth cancer. Med Hypotheses Furin-mediated protein processing in infectious diseases and cancer Genotype and phenotype of COVID-19: Their roles in pathogenesis Fusion of enveloped viruses in endosomes Coronavirus spike proteins in viral entry and pathogenesis Proteolytic activation of the SARScoronavirus spike protein: cutting enzymes at the cutting edge of antiviral research Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Essential role for collectrin in renal amino acid transport Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System The pivotal link between ACE2 deficiency and SARS-CoV-2 infection Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection Characterization of a secreted form of human furinendoprotease Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19 HCA Lung Biological Network, SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues FurinDB: a database of 20-residue furin cleavage site motifs, substrates and their associated drugs Clinical features of patients infected with 2019 novel coronavirus in wuhan, China Proprotein convertase FURIN constrains Th2 differentiation and is critical for host resistance against Toxoplasma gondii T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens